In the present study, using an orthotopic transplantation model, we demonstrated that the administration of anti-TNFα mAb inhibits tumor growth, and the underlying mechanisms involves the suppression of stromal response, enhancement of tumor immunity, inhibition of angiogenesis, and increased apoptosis. The gene discussed is TNF; the disease is neoplasm.